抗病毒三十六计——浅谈小分子抗病毒药物发展史

doi:10.12461/PKU.DXHX202403108

Abstract

Abstract: Viruses have long been a significant threat to human survival and development, with recent events such as the COVID-19 pandemic vividly highlighting their dangers. Small molecule drugs have historically played a crucial role in humanity’s efforts to combat diseases. In the fight against viruses, humans have developed a range of strategies, with small molecule antiviral drugs occupying a pivotal position. Drawing inspiration from the classic “Thirty-Six Stratagems” of ancient Chinese military tactics, this article provides a concise overview of the developmental history of small molecule antiviral drugs, focusing on the design principles and mechanisms of representative drugs like idoxuridine, saquinavir, and oseltamivir. Furthermore, the article provides insights into future directions for small molecule antiviral drugs and antiviral methodologies.

Key words: Antivirus, Small molecule drugs, Thirty-Six stratagems

Zheqi Wang, Yawen Lin, Shunliu Deng, Huijun Zhang, Jinmei Zhou. Antiviral Strategies: A Brief Review of the Development History of Small Molecule Antiviral Drugs[J].University Chemistry, 2024, 39(9): 85-93.

References

[1] 刘宁, 李文刚. 时珍国医国药, 2008, 18 (9), 2298.
[2] Voigt, E. A.; Kennedy, R. B.; Poland, G. A. Expert Rev. Vaccines 2016, 15, 1197.
[3] Baer, G. M. The Natural History of Rabies, 2nd ed.; Elsevier Science CA: New York, NY, USA, 2007; pp. 11–19.
[4] Isaacs, A.; Lindenmann, J. Proc. R. Soc. Lond. Ser. B 1957, 147, 258.
[5] Pestka, S. J. Biol. Chem. 2007, 282, 20047.
[6] Beck, H.; Härter, M.; Haß, B.; Schmeck, C.; Baerfacker, L. Drug Discov. Today 2022, 27, 1560.
[7] Clercq, E.; Li, G. Clin. Microbiol. Rev. 2016, 29, 695.
[8] Clercq, E. Nat. Rev. Microbiol. 2004, 2, 704.
[9] Ryu, W. S. Molecular Virology of Human Pathogenic Viruses; Elsevier: Amsterdam, the Netherlands, 2017; pp 31−45.
[10] Connolly, S.; Jackson, J.; Jardetzky, T.; Longnecker, R. Nat. Rev. Microbiol. 2011, 9, 369.
[11] 王萍, 饶红华, 林世静, 刘姗姗, 马磊. 化学教育(中英文), 2023, 44 (8), 1.
[12] Hitchings, G. H.; Elion, G. B.; Falco, E.; Russell, P. B.; Vanderwerff, H. Biol. Chem. 1950, 183, 1.
[13] Bieber, S.; Nigrelli, R. F.; Hitchings, G. H. Proc. Soc. Exp. Biol. Med. 1952, 79, 430.
[14] 孙彦莹, 康东伟, 高升华, 展鹏, 刘新泳. 中国药物化学杂志, 2021, 31 (1), 55.
[15] Prusoff, W. H. Biochim. Biophys. Acta 1959, 32, 295.
[16] Herrmann, E. C. Pro. Soc. Exp. Biol. Med. 1961, 107, 142.
[17] Kaufman, H. E.; Martola, E. L.; Dohlman, C. Arch. Ophthalmol. 1962, 68, 235.
[18] Wilhelmus, K. R. Cochrane Database Syst. Rev. 2010, 12, CD002898.
[19] Clercq, E. Clin. Microbiol. Rev. 1997, 10, 674.
[20] Clercq, E. Biochem. Pharmacol. 2004, 68, 2301.
[21] Andrei, G.; Sienaert, R.; McGuigan, C.; Clercq, E.; Balzarini, J.; Snoeck, R. Antimicrob. Agents Chemother. 2005, 49, 1081.
[22] Clercq, E.; Ashwell, M.; Jones, A. S.; Kumar, A.; Sayers, J. R.; Walker, R. T.; Sakuma, T. Tetrahedron 1987, 43, 4601.
[23] Asakura, J.; Robins, M. J. J. Org. Chem. 1990, 55, 4928.
[24] Glinski, R. P.; Khan, M. S.; Kalamas, R. L.; Sporn, M. B. J. Org. Chem. 1973, 38, 4299.
[25] Chu, C. K.; Beach, J. W.; Ullas, G. V.; Kosugi, Y. Tetrahedron Lett. 1988, 29, 5349.
[26] Fleet, G. W. J.; Son, J. C.; Derome, A. E. Tetrahedron 1988, 44, 625.
[27] Goodyear, M. D.; Hill, M. L.; West, J. P.; Whitehead, A. J. Tetrahedron Lett. 2005, 46, 8535.
[28] 王先登, 陈国华, 熊成文. 中国药物化学杂志, 2008, 18 (3), 203.
[29] Jin, H. L.; Siddiqui, M. A.; Evans, C. A.; Tse, H. L. A.; Mansour, T. S.; Goodyear, M. D.; Ravenscroft, P.; Beels, C. D. J. Org. Chem. 1995, 60, 2621.
[30] 孟静芳, 吴雪松, 岑均达. 中国医药工业杂志, 2005, 36 (10), 589.
[31] Freed, E. O. Virology 1998, 251, 1.
[32] Kramer, R. A.; Schaber, M. D.; Skalka, A. M.; Ganguly, K.; Wong, S. F.; Reddy, E. P. Science 1986, 231, 1580.
[33] Roberts, N. A.; Martin, J. A.; Kinchington, D.; Broadhurst, A. V.; Craig, J. C.; Duncan, I. B.; Galpin, S. A.; Handa, B. K.; Kay, J.; Machin, P. J.; et al. Science 1990, 248, 358.
[34] Kaldor, S. W.; Kalish, V. J.; Davies, J. F.; Shetty, B. V.; Fritz, J. E.; Appelt, K.; Burgess, J. A.; Campanale, K. M.; Chirgadze, N. Y.; Clawson, D. K.; et al. J. Med. Chem. 1997, 40, 3979.
[35] Inaba, T.; Birchler, A. G.; Yamada, Y.; Sagawa, S.; Yokota, K.; Ando, K.; Uchida, I. J. Org. Chem. 1998, 63, 7582.
[36] Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merrett, J. H.; et al. J. Org. Chem. 1994, 59, 3656.
[37] Corey, E. J.; Zhang, F. Y. Angew. Chem. Int. Ed. 1999, 38, 1931.
[38] Kim, B. M.; Bae, S. J.; So, S. M.; Yoo, H. T.; Chang, S. K.; Lee, J. H.; Kang, J. S. Org. Lett. 2001, 3, 2349.
[39] Ghosh, A. K.; Kincaid, J. F.; Walters, D. E.; Chen, Y.; Chaudhuri, N. C.; Thompson, W. J.; Culberson, C.; Fitzgerald, P. M. D.; Lee, H. Y.; McKee, S. P.; et al. J. Med. Chem. 1996, 39, 3278.
[40] Yu, R. H.; Polniaszek, R. P.; Becker, M. W.; Cook, C. M.; Yu. L. H. L. Org. Process Res. Dev. 2007, 11, 972.
[41] Canoy, W. L.; Cooley, B. E.; Corona, J. A.; Lovelace, T. C.; Millar, A.; Weber, A. M.; Xie, S. P.; Zhang, Y. Org. Lett. 2008, 10, 1103.
[42] Ghosh, A. K.; Shin, D.; Packiarajan, M. Chem. Commun. 1999, 1025.
[43] Benedetti, F.; Norbedo, S. Chem. Commun. 2001, 203.
[44] 曾祥兴, 李文刚. 时珍国医国药, 2008, 18 (9), 2298.
[45] 陈丹阳, 郑思钰, 郑锐林, 苏静瑶, 朱冰, 李英华. 检验医学, 2023, 38 (7), 696.
[46] Skehel, J. J.; Wiley, D. C. Annu. Rev. Biochem. 2000, 69, 531.
[47] Palese, P.; Jobita, K.; Ueda, M.; Compans, R. W. Virology 1974, 61, 397.
[48] Liu, C.; Eichelberger, M. C.; Compans, R. W.; Air, G. M. J. Virol. 1995, 69, 1099.
[49] Balakin, K. V.; Filosa, R.; Lavrenov, S. N.; Mkrtchyan, A. S.; Nawrozkij, M. B.; Novakov, I. A. Russ. Chem. Rev. 2018, 87, 509.
[50] Kadam, R. U.; Wilson, I. A. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, 206.
[51] Air, G. M.; Laver, W. G.; Luo, M.; Stray, S. J.; Legrone, G.; Webster, R. G. Virology 1990, 177, 578.
[52] Blok, J.; Air, G. M.; Laver, W. G.; Ward, C. W.; Lilley, G. G.; Wood, E. F.; Roxburgh, C. M.; Inglis, A. S. Virology 1982, 119, 109.
[53] Colman, P. M. Pept. Protein Rev. 1984, 4, 215.
[54] Itzstein, M.; Wu, W. Y.; Kok, G. B.; Pegg, M. S.; Dyason, J. C.; Jin, B.; Phan, T. V.; Smythe, M. L.; White, H. F.; Oliver, S. W.; et al. Nature 1993, 363, 418.
[55] Chong, A. K. J.; Pegg, M. S.; Taylor, N. R.; von Itzstein, M. Eur. J. Biochem. 1992, 207, 335.
[56] Kim, C. U.; Lew, W.; Williams, M. A.; Liu, H. T.; Zhang, L. J.; Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Tai, C. Y.; et al. J. Am. Chem. Soc. 1997, 119, 681.
[57] Rohloff, J. C.; Kent, K. M.; Postich, M. J.; Becker, M. W.; Chapman, H. H.; Kelly, D. E.; Lew, W.; Louie, M. S.; McGee, L. R.; Prisbe, E. J.; et al. J. Org. Chem.; 1998, 63, 4545.
[58] Federspiel, M.; Fischer, R.; Hennig, M.; Mair, H. J.; Oberhauser, T.; Rimmler, G.; Albiez, T.; Bruhin, J.; Estermann, H.; Gandert, C.; et al. Org. Process Res. Dev. 1999, 3, 266.
[59] 占弋丰, 张小林, 欧阳红霞. 化工中间体, 2012, 9 (5), 1.
[60] 张伟东, 崔恩惠, 徐露, 张凯育, 罗巧云. 化工设计通讯, 2019, 45 (11), 108.
[61] 张中朋. 中国现代中药, 2006, 8 (4), 41.
[62] Sagandira, C. R.; Mathe, F. M.; Guyo, U.; Watts, P. Tetrahedron 2020, 76, 131440.
[63] Hayashi, Y. J. Org. Chem. 2021, 86, 1.
[64] 曹瑞源, 赵磊, 钟武. 临床药物治疗杂志, 2018, 16 (1), 1.

Antiviral Strategies: A Brief Review of the Development History of Small Molecule Antiviral Drugs

PDF

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 2

Metrics

Recommended 0

[1]	Bo Yuan, Chenyun Feng, Yaofeng Yuan. Research Progress on Small-Molecule Drugs for Treating COVID-19 [J]. University Chemistry, 2023, 38(8): 85-94.
[2]	Shengzhi Xue, Jinlong Bi, Xin-Ping Hui, Quan-Xiang Wu. Research Progress of Commercial Small-Molecule Antiviral Drugs [J]. University Chemistry, 2023, 38(12): 91-105.